Growth Metrics

Eli Lilly (LLY) Enterprise Value Growth (5y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -13.13%
Dec 31, 2025 -15.75%
Sep 30, 2025 -23.28%
Jun 30, 2025 -9.45%
Mar 31, 2025 -13.60%
Dec 31, 2024 -7.34%
Sep 30, 2024 -16.92%
Jun 30, 2024 -7.51%
Mar 31, 2024 -4.03%
Dec 31, 2023 16.55%
Sep 30, 2023 21.28%
Jun 30, 2023 16.71%
Mar 31, 2023 5.49%
Dec 31, 2022 23.49%
Sep 30, 2022 17.38%
Jun 30, 2022 13.34%
Mar 31, 2022 6.62%
Dec 31, 2021 8.95%
Sep 30, 2021 2.89%
Jun 30, 2021 4.86%
Mar 31, 2021 0.85%
Dec 31, 2020 4.63%
Sep 30, 2020 4.25%
Jun 30, 2020 12.04%
Mar 31, 2020 16.61%
Dec 31, 2019 13.38%
Sep 30, 2019 19.99%
Jun 30, 2019 14.84%
Mar 31, 2019 16.97%
Dec 31, 2018 -5.39%
Sep 30, 2018 -8.19%
Jun 30, 2018 -7.80%
Mar 31, 2018 -0.01%
Dec 31, 2017 -6.99%
Sep 30, 2017 0.10%
Jun 30, 2017 -0.38%
Mar 31, 2017 7.01%
Dec 31, 2016 2.88%
Sep 30, 2016 9.15%
Jun 30, 2016 9.16%
Mar 31, 2016 15.03%
Dec 31, 2015 8.02%
Sep 30, 2015 6.90%
Jun 30, 2015 4.21%
Mar 31, 2015 2.86%
Dec 31, 2014 -1.37%
Sep 30, 2014 -4.07%
Jun 30, 2014 -7.93%
Mar 31, 2014 -9.44%